Amyloid‐β‐induced toxicity of primary neurons is dependent upon differentiation‐associated increases in tau and cyclin‐dependent kinase 5 expression
暂无分享,去创建一个
[1] Xudong Huang,et al. Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.
[2] Matthew P. Frosch,et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[3] I. Sponne,et al. Apoptotic Neuronal Cell Death Induced by the Non-fibrillar Amyloid-β Peptide Proceeds through an Early Reactive Oxygen Species-dependent Cytoskeleton Perturbation* , 2003, The Journal of Biological Chemistry.
[4] M. Mullan,et al. p35/Cdk5 pathway mediates soluble amyloid‐β peptide‐induced tau phosphorylation in vitro , 2002, Journal of neuroscience research.
[5] L. Tsai,et al. A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains , 2002, FEBS letters.
[6] K. Zou,et al. A Novel Function of Monomeric Amyloid β-Protein Serving as an Antioxidant Molecule against Metal-Induced Oxidative Damage , 2002, The Journal of Neuroscience.
[7] Xiantao Wang,et al. Signaling Events in Amyloid β-Peptide-induced Neuronal Death and Insulin-like Growth Factor I Protection* , 2002, The Journal of Biological Chemistry.
[8] M. Vitek,et al. Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] E. Mandelkow,et al. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.
[10] L. Tsai,et al. Calpain-mediated Cleavage of the Cyclin-dependent Kinase-5 Activator p39 to p29* , 2002, The Journal of Biological Chemistry.
[11] C. Casal,et al. Relationship between β-AP peptide aggregation and microglial activation , 2002, Brain Research.
[12] M. A. Ajmone-Cat,et al. Astrocytes contribute to neuronal impairment in βA toxicity increasing apoptosis in rat hippocampal neurons , 2001, Glia.
[13] R. Maccioni,et al. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons. , 2001, Experimental cell research.
[14] Ashley I. Bush,et al. Redox-active iron mediates amyloid-β toxicity , 2001 .
[15] H. Soininen,et al. β-Amyloid (1–42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality , 2001, Neurochemistry International.
[16] G. Johnson,et al. Tau Protein Is Hyperphosphorylated in a Site‐Specific Manner in Apoptotic Neuronal PC12 Cells , 2000, Journal of neurochemistry.
[17] P. Greengard,et al. Neuron‐Specific Phosphorylation of Alzheimer's β‐Amyloid Precursor Protein by Cyclin‐Dependent Kinase 5 , 2000, Journal of neurochemistry.
[18] R. Maccioni,et al. Increase in the expression of the neuronal cyclin‐dependent protein kinase cdk‐5 during differentiation of N2A neuroblastoma cells , 2000, Neuroreport.
[19] Xiongwei Zhu,et al. Cyclin' toward dementia , 2000, Journal of neuroscience research.
[20] Jerry H. Wang,et al. The Expression of Cdk5, p35, p39, and Cdk5 Kinase Activity in Developing, Adult, and Aged Rat Brains , 2000, Neurochemical Research.
[21] Xudong Huang,et al. Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc* , 2000, The Journal of Biological Chemistry.
[22] D. Butterfield,et al. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. , 2000, Journal of structural biology.
[23] L. Tsai,et al. Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.
[24] Robert J. Cotter,et al. Elevated Aβ42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of AβPP Metabolism , 2000 .
[25] L. Tsai,et al. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.
[26] R. Maccioni,et al. Inhibition of tau phosphorylating protein kinase cdk5 prevents β‐amyloid‐induced neuronal death , 1999, FEBS letters.
[27] B. Volk,et al. Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[28] E. Mandelkow,et al. Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease. , 1998, European journal of cell biology.
[29] Bruce A. Yankner,et al. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity , 1998, Nature Medicine.
[30] E. Mandelkow,et al. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. , 1998, Molecular biology of the cell.
[31] Xudong Huang,et al. Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.
[32] J. Silver,et al. Astrocytes Regulate Microglial Phagocytosis of Senile Plaque Cores of Alzheimer's Disease , 1998, Experimental Neurology.
[33] D. Schubert,et al. Cytotoxic Amyloid Peptides Inhibit Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction by Enhancing MTT Formazan Exocytosis , 1997, Journal of neurochemistry.
[34] L. Tsai,et al. Mice Lacking p35, a Neuronal Specific Activator of Cdk5, Display Cortical Lamination Defects, Seizures, and Adult Lethality , 1997, Neuron.
[35] Richard Hollister,et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.
[36] M. Mattson,et al. A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide , 1997, Journal of neurochemistry.
[37] Y. Ihara,et al. τ Is Widely Expressed in Rat Tissues , 1996 .
[38] J. Morris,et al. Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.
[39] L. Tsai,et al. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. , 1996, Genes & development.
[40] M. Mullan,et al. β-Amyloid-mediated vasoactivity and vascular endothelial damage , 1996, Nature.
[41] B. Yankner,et al. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro , 1995, Nature.
[42] D. Butterfield,et al. A beta (25-35) peptide displays H2O2-like reactivity towards aqueous Fe2+, nitroxide spin probes, and synaptosomal membrane proteins. , 1995, Life sciences.
[43] M. Memo,et al. Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro. , 1995, Brain research. Molecular brain research.
[44] J. Gallo,et al. Tau isoform expression and phosphorylation state during differentiation of cultured neuronal cells , 1995, FEBS letters.
[45] D. Butterfield,et al. Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.
[46] S. Pelech. Networking with proline-directed protein kinases implicated in Tau phosphorylation , 1995, Neurobiology of Aging.
[47] E. Vanmechelen,et al. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.
[48] M. Mattson,et al. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium , 1995, Brain Research.
[49] B. Yankner,et al. β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding , 1995, Neuron.
[50] K. Jellinger,et al. Decreased Catalase Activity but Unchanged Superoxide Dismutase Activity in Brains of Patients with Dementia of Alzheimer Type , 1995, Journal of neurochemistry.
[51] S. Matsuyama,et al. Tau‐like immunoreactivity in Alzheimer and control skin fibroblasts , 1994, Journal of neuroscience research.
[52] M. Memo,et al. Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration , 1994, Cellular and Molecular Neurobiology.
[53] P. Cohen,et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. , 1994, The Biochemical journal.
[54] D. Selkoe,et al. Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[55] M. Vandermeeren,et al. Microtubule-associated protein tau epitopes are present in fiber lesions in diverse muscle disorders. , 1994, The American journal of pathology.
[56] N. Hirokawa,et al. Altered microtubule organization in small-calibre axons of mice lacking tau protein , 1994, Nature.
[57] J. McCarty,et al. Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability. , 1994, Journal of cell science.
[58] W. Klein,et al. Microtubule-Associated Protein Tau Is Hyperphosphorylated during Mitosis in the Human Neuroblastoma Cell Line SH-SY5Y , 1994, Experimental Neurology.
[59] L. Tsai,et al. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. , 1993, Development.
[60] J. Brion,et al. Developmental Changes in τ Phosphorylation: Fetal τ Is Transiently Phosphorylated in a Manner Similar to Paired Helical Filament‐τ Characteristic of Alzheimer's Disease , 1993, Journal of neurochemistry.
[61] J. Trojanowski,et al. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[62] John Q. Trojanowski,et al. Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding , 1993, Neuron.
[63] K. Imahori,et al. τ Protein Kinase II Is Involved in the Regulation of the Normal Phosphorylation State of τ Protein , 1993 .
[64] G. Cole,et al. Vitamin E protects nerve cells from amyloid βprotein toxicity , 1992 .
[65] G. Drewes,et al. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state. , 1992, The EMBO journal.
[66] G. Lee,et al. Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. , 1992, Journal of cell science.
[67] R. Liem,et al. Primary structure of high molecular weight tau present in the peripheral nervous system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[68] R. Crowther,et al. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[69] M. Mattson,et al. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[70] M. Tabaton,et al. Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[71] D. Kirschner,et al. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.
[72] R. Tucker,et al. The roles of microtubule-associated proteins in brain morphogenesis: a review , 1990, Brain Research Reviews.
[73] C. Cotman,et al. β-Amyloid protein promotes neuritic branching in hippocampal cultures , 1990, Neuroscience Letters.
[74] N. Hirokawa,et al. Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA , 1989, The Journal of cell biology.
[75] Kenneth S. Kosik,et al. Developmentally regulated expression of specific tau sequences , 1989, Neuron.
[76] C. Cotman,et al. Amyloid beta protein enhances the survival of hippocampal neurons in vitro. , 1989, Science.
[77] M. L. Schmidt,et al. Distribution of tau proteins in the normal human central and peripheral nervous system. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[78] M. Kirschner,et al. Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells , 1988, The Journal of cell biology.
[79] M. Kirschner,et al. Tau protein function in living cells , 1986, The Journal of cell biology.
[80] Sumire V. Kobayashi,et al. Association of Tau Protein with Microtubules in Living Cells , 1986, Annals of the New York Academy of Sciences.
[81] J. Ávila,et al. Quantitation and characterization of tau factor in porcine tissues. , 1986, Biochimica et biophysica acta.
[82] A. Frankfurter,et al. The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.
[83] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[84] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[85] INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .
[86] K. Imahori,et al. Tau protein immunoreactivity in muscle fibers with rimmed vacuoles differs from that in regenerating muscle fibers , 2004, Acta Neuropathologica.
[87] Yasuo Ihara,et al. Muscle fiber degeneration in distal myopathy with rimmed vacuole formation , 2004, Acta Neuropathologica.
[88] D. Selkoe,et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[89] C. Casal,et al. Relationship between beta-AP peptide aggregation and microglial activation. , 2002, Brain research.
[90] M. Vitek,et al. Tau is essential to beta -amyloid-induced neurotoxicity. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[91] R. Maccioni,et al. AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. , 2002, Journal of Alzheimer's disease : JAD.
[92] M. Smith,et al. Redox-active iron mediates amyloid-beta toxicity. , 2001, Free radical biology & medicine.
[93] S. Schippling,et al. Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. , 2001, Free radical biology & medicine.
[94] S. Arlt,et al. Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma , 2001 .
[95] T. Beach,et al. Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. , 2000, The American journal of pathology.
[96] R. Martins,et al. Anti-apoptotic action of Alzheimer Ab , 1999 .
[97] Xudong Huang,et al. ANTI-APOPTOTIC ACTION OF ALZHEIMER BETA AMYLOID , 1999 .
[98] C. Geula,et al. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. , 1998, Nature medicine.
[99] W R Markesbery,et al. Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.
[100] M. Mullan,et al. beta-Amyloid-mediated vasoactivity and vascular endothelial damage. , 1996, Nature.
[101] G. Perry,et al. beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease. , 1996, The American journal of pathology.
[102] Y. Ihara,et al. Tau is widely expressed in rat tissues. , 1996, Journal of Neurochemistry.
[103] M. Mattson,et al. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. , 1996, Molecular neurobiology.
[104] C. Behl,et al. Hydrogen peroxide mediates amyloid beta protein toxicity. , 1994, Cell.
[105] K. Imahori,et al. Tau protein kinase II is involved in the regulation of the normal phosphorylation state of tau protein. , 1993, Journal of neurochemistry.
[106] G. Cole,et al. Vitamin E protects nerve cells from amyloid beta protein toxicity. , 1992, Biochemical and biophysical research communications.
[107] K. Boekelheide,et al. Tau, the neuronal heat-stable microtubule-associated protein, is also present in the cross-linked microtubule network of the testicular spermatid manchette. , 1992, Biology of reproduction.
[108] Papasozomenos Sc. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications. , 1989 .
[109] S. Papasozomenos. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[110] L. Binder,et al. Phosphorylation determines two distinct species of Tau in the central nervous system. , 1987, Cell motility and the cytoskeleton.
[111] G. Glenner,et al. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.